Scottish Medicines Consortium accepts PROSTAP® SR DCS & PROSTAP® 3 DCS (leuprorelin acetate) to treat early and advanced breast cancer[1] [2] London, UK – 8 February 2021, Takeda is pleased to ...
Takeda UK has announced the launch of a new presentation of Prostap, its treatment for prostate cancer in men and endometriosis and uterine fibroids in women. Takeda UK has announced the launch of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback